Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 1.27M | 1.42M | +149.5K (+11.8%) |
| Value | $2.41M | $1.15M | −$1.25M (−52.1%) |
New holders (8)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 48,374 | $39.4K | 0.00% |
| Virtu Financial LLC | 27,836 | $23.0K | 0.00% |
| ACT Advisors, LLC. | 21,284 | $17.3K | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 17,750 | $14.0K | 0.00% |
| Renaissance Technologies LLC | 14,674 | $11.9K | 0.00% |
| Squarepoint Ops LLC | 12,537 | $10.2K | 0.00% |
| UBS Group AG | 5,961 | $4.85K | 0.00% |
| SBI Securities Co., Ltd. | 270 | $220 | 0.00% |
Sold out (4)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| LPL Financial LLC | 44,780 | $85.1K |
| StoneX Group Inc. | 17,800 | $33.8K |
| Tocqueville Asset Management L.P. | 10,000 | $19.0K |
| Simplex Trading, LLC | 1,161 | $2.00K |